Camarillo, CA, United States of America

Shiwen Zhang

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shiwen Zhang

Introduction

Shiwen Zhang is a prominent inventor based in Camarillo, California. She has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies for cancer treatment. With a total of two patents to her name, her work is paving the way for advancements in medical therapies.

Latest Patents

Shiwen Zhang's latest patents focus on antibodies and methods for making and using these antibodies. One of her notable inventions includes novel antibodies for Claudin 18.2, which are described in detail in her patents. These antibodies are accompanied by pharmaceutical compositions and methods of use aimed at treating cancer, showcasing her commitment to addressing critical health challenges.

Career Highlights

Throughout her career, Shiwen Zhang has worked with reputable companies in the pharmaceutical industry. She has been associated with Askgene Pharma Inc. and Jiangsu Aosaikang Pharmaceutical Co., Ltd. Her experience in these organizations has contributed to her expertise in antibody development and cancer treatment.

Collaborations

Shiwen Zhang has collaborated with several professionals in her field, including Yuefeng Lu and Kurt Shanebeck. These collaborations have likely enhanced her research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Shiwen Zhang's contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment, highlight her role as an influential inventor. Her work continues to inspire advancements in medical therapies and showcases the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…